Company / Return on Assets (ROA)
Pfizer Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
3.7%
FY2025
5-year range
3.7% / 9.7%
FY2021-FY2025
Trend
-0.8%
vs FY2024
Sector context
#44 of 213
Health Care
What the data says
Pfizer's return on assets (roa) of 3.7% is higher than 79% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from 3.7% in FY2025 to 9.7% in FY2023.
Based on SEC 10-K filings.
3.7% in FY2025 with a 5-year CAGR of -2.2%. Top quartile in the Health Care sector.
Declined from 9.7% to 3.7% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -0.9pp
- 5-Year Change
- -2.2pp
- 10-Year Change
- -
Sector benchmark
+115.5% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 0.8% year-over-year.
- Currently 27.9pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 3.7% | -0.8% |
| FY2024 | 3.8% | -61.2% |
| FY2023 | 9.7% | +109.1% |
| FY2022 | 4.6% | -47.5% |
| FY2021 | 8.8% | +48.7% |
| FY2020 | 5.9% | -37.9% |
| FY2019 | 9.6% | +111.0% |
| FY2018 | 4.5% | +11.9% |
| FY2017 | 4.0% | -23.9% |
| FY2016 | 5.3% | +27.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026